...
首页> 外文期刊>Journal of proteome research >pValid: Validation Beyond the Target-Decoy Approach for Peptide Identification in Shotgun Proteomics
【24h】

pValid: Validation Beyond the Target-Decoy Approach for Peptide Identification in Shotgun Proteomics

机译:PVALID:验证超出霰弹枪蛋白质组学中肽鉴定的目标 - 诱饵方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

As the de facto validation method in mass spectrometry-based proteomics, the target-decoy approach determines a threshold to estimate the false discovery rate and then filters those identifications beyond the threshold. However, the incorrect identifications within the threshold are still unknown and further validation methods are needed. In this study, we characterized a framework of validation and investigated a number of common and novel validation methods. We first defined the accuracy of a validation method by its false-positive rate (FPR) and false-negative rate (FNR) and, further, proved that a validation method with lower FPR and FNR led to identifications with higher sensitivity and precision. Then we proposed a validation method named pValid that incorporated an open database search and a theoretical spectrum prediction strategy via a machine-learning technology. pValid was compared with four common validation methods as well as a synthetic peptide validation method. Tests on three benchmark data sets indicated that pValid had an FPR of 0.03% and an FNR of 1.79% on average, both superior to the other four common validation methods. Tests on a synthetic peptide data set also indicated that the FPR and FNR of pValid were better than those of the synthetic peptide validation method. Tests on a large-scale human proteome data set indicated that pValid successfully flagged the highest number of incorrect identifications among all five methods. Further considering its cost-effectiveness, pValid has the potential to be a feasible validation tool for peptide identification.
机译:作为基于质谱的蛋白质组学的De Facto验证方法,目标 - 诱饵方法确定阈值以估计错误发现率,然后过滤超出阈值的标识。但是,阈值内的错误标识仍然是未知的,并且需要进一步的验证方法。在这项研究中,我们的特点是验证框架,并调查了许多常见和新的验证方法。我们首先通过其假阳性率(FPR)和假负速率(FNR)来定义验证方法的准确性,并进一步证明了具有较低FPR和FNR的验证方法,导致具有更高灵敏度和精度的识别。然后,我们提出了一种名为PVALD的验证方法,该方法通过机器学习技术结合了开放数据库搜索和理论频谱预测策略。将PVALID与四种常见的验证方法以及合成肽验证方法进行比较。三个基准数据集测试表明,PVALID的FPR为0.03%,平均FNR为1.79%,均优于其他四种常见验证方法。对合成肽数据集的测试也表明,PVALID的FPR和FNR优于合成肽验证方法的FPR和FNR。对大规模人类蛋白质组数据集的测试表明,PVALID在所有五种方法中成功标记了最高的错误标识。进一步考虑其成本效益,PVALID具有肽鉴定的可行验证工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号